Other UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator PharmaphorumBoehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI ML in the UK.OtherRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) Pharmaphorum Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI ML in the UK. OtherRead full story Post navigation Previous: Update: Lilly makes $7bn bid for in vivo CAR-T firm KeloniaNext: FDA Policy Tracker 2026: Psychedelics get a boost Related Stories Other ‘Seismic shift’ as obesity overtakes cancer for R&D returns pharminent May 5, 2026 Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026 Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech pharminent April 29, 2026
